<?OLF?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="article-commentary"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Eur Acad Dermatol Venereol</journal-id><journal-id journal-id-type="iso-abbrev">J Eur Acad Dermatol Venereol</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1468-3083</journal-id><journal-id journal-id-type="publisher-id">JDV</journal-id><journal-title-group><journal-title>Journal of the European Academy of Dermatology and Venereology</journal-title></journal-title-group><issn pub-type="ppub">0926-9959</issn><issn pub-type="epub">1468-3083</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1111/jdv.16646</article-id><article-id pub-id-type="publisher-id">JDV16646</article-id><article-categories><subj-group subj-group-type="overline"><subject>Commentary</subject></subj-group><subj-group subj-group-type="heading"><subject>Commentary</subject></subj-group></article-categories><title-group><article-title>Active implications for dermatologists in &#x0201c;SARS&#x02010;CoV&#x02010;2 era&#x0201d;: Personal experience and review of literature</article-title></title-group><contrib-group><contrib id="jdv16646-cr-0001" contrib-type="author"><name><surname>Campanati</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0002" contrib-type="author"><name><surname>Brisigotti</surname><given-names>V.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0003" contrib-type="author" corresp="yes"><name><surname>Diotallevi</surname><given-names>F.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref><address><email>federico.diotallevi@hotmail.it</email></address></contrib><contrib id="jdv16646-cr-0004" contrib-type="author"><name><surname>D&#x02019;Agostino</surname><given-names>G.M.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0005" contrib-type="author"><name><surname>Paolinelli</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0006" contrib-type="author"><name><surname>Radi</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0007" contrib-type="author"><name><surname>Rizzetto</surname><given-names>G.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0008" contrib-type="author"><name><surname>Sapigni</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0009" contrib-type="author"><name><surname>Tagliati</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdv16646-cr-0010" contrib-type="author"><name><surname>Offidani</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="jdv16646-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jdv16646-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Dermatological Clinic Department of Clinical and Molecular Sciences</named-content>
<institution>Polytechnic University of the Marche Region</institution>
<city>Ancona</city>
<country country="IT">Italy</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Corresponding author<break/>
Federico Diotallevi, Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Via Conca 71, 60020, Ancona, Italy<break/>
Email: <email>federico.diotallevi@hotmail.it</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>5</month><year>2020</year></pub-date><elocation-id>10.1111/jdv.16646</elocation-id><permissions><!--<copyright-statement content-type="issue-copyright"> Journal of the European Academy of Dermatology and Venereology &#x000a9; 2020 European Academy of Dermatology and Venereology <copyright-statement>--><copyright-statement content-type="article-copyright">This article is protected by copyright. All rights reserved.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JDV-9999-na.pdf"/><abstract id="jdv16646-abs-0001"><title>Abstract</title><p>On December 31, 2019, from the Chinese city of Wuhan, Hubei, comes the first case of "atypical ARDS/ interstitial pneumonia". On February 11, 2020 the WHO officially announced the name of the emergent disease associated with new coronavirus identified as SARS&#x02010;CoV&#x02010;2 (Severe Acute Respiratory Syndrome Coronavirus &#x02010;2): COVID&#x02010;19 (Coronavirus Disease 2019) (1). On February 13, 72000 cases have been officially recorded in China, among which 15000 were registered in Hubei province only, with 242 deaths in a single day. After that, Chinese republic has ordered drastic containment measures for fighting SARS&#x02010;CoV&#x02010;2 virus spreading (1).</p></abstract><kwd-group><kwd id="jdv16646-kwd-0001">coronavirus</kwd><kwd id="jdv16646-kwd-0002">nCoV</kwd><kwd id="jdv16646-kwd-0003">SARS&#x02010;CoV&#x02010;2</kwd><kwd id="jdv16646-kwd-0004">COVID&#x02010;19</kwd><kwd id="jdv16646-kwd-0005">dermatology</kwd><kwd id="jdv16646-kwd-0006">skin diseases</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="21"/><word-count count="180"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>accepted-manuscript</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:08.06.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jdv16646-ntgp-0001"><fn id="jdv16646-note-1001"><p>This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.16646</p></fn></fn-group></notes></front></article>